![Angela Cacace](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Angela Cacace
Direttore Tecnico/Scientifico/R&S presso
ARVINAS, INC.
Patrimonio netto: 1 M $ in data 31/07/2026
Profilo
Dr. Angela Cacace is a Chief Scientific Officer at Arvinas, Inc. Dr. Cacace was previously employed as a Neuroscience Director by Bristol Myers Squibb Co. She received her undergraduate degree from Fairfield University and a doctorate degree from The Trustees of Columbia University in The City of New York.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ARVINAS, INC. 0,28% | 17/06/2026 | 180.390 ( 0,28% ) | 1 M $ | 31/07/2026 |
Posizioni attive di Angela Cacace
| Società | Posizione | Inizio |
|---|---|---|
| ARVINAS, INC. | Direttore Tecnico/Scientifico/R&S | 17/06/2024 |
Precedenti posizioni note di Angela Cacace
| Società | Posizione | Fine |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formazione di Angela Cacace
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
33
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
